Safety of multicomponent meningococcal group B vaccine

Update: 2018-04-26

Description

Philip Bryan joins The Lancet Child & Adolescent Health to discuss the safety of multicomponent meningococcal group B vaccine (4CMenB) in the UK’s infant immunisation programme.

Comments

In Channel

The rights of children

2019-11-2038:14

Prescription opioids in Australia

2019-10-0811:11

Undetected flu in infants

2019-09-0313:21

School and adolescent health

2019-07-1319:09

Gender expression in adolescence and health

2019-06-0117:50

Adolescent pregnancy and early child undernutrition

2019-05-1713:45

Voices from the field on adolescent mental health

2019-03-1440:18

Preterm infants in single rooms

2019-01-0711:57

Cannabis potency and adolescent health

2018-12-2206:54

PEGASUS program for TBI

2018-11-2308:42

Intraocular lens implantation for children

2018-10-3006:21

Recreational screen time for children

2018-09-2710:08

$Rib fracture diagnosis in children$

Rib fracture diagnosis in children

2018-09-2604:52

Mental and sexual health outcomes after sexual assault in adolescents

2018-07-1905:49

Psychotic experiences and disordered eating behaviours

2018-06-2209:22

The Global Partnership for Education

2018-05-2509:18

Treatment of paediatric narcolepsy with sodium oxybate

2018-05-2407:29

Safety of multicomponent meningococcal group B vaccine

2018-04-2609:05

Adolescent-to-parent abuse

2018-03-1407:18

Diagnostic timeliness in adolescents with cancer

2018-01-3012:57

00:00

1.0x

Safety of multicomponent meningococcal group B vaccine

#box-pro-ellipsis-176475584955432{-webkit-line-clamp:2;}Safety of multicomponent meningococcal group B vaccine

Safety of multicomponent meningococcal group B vaccine

The Lancet

Safety of multicomponent meningococcal group B vaccine